SENSORIUM
Live / Applied — Response to non-final action entered (as of 30 Mar 2026)
What this means for you
Not registered yet, but its 17 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99141812
- Mark type
- Stylized text
- Filed
- 17 Apr 2025
- Attorney of record
- John L. DuPre'
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of diseases of the central nervous system, psychiatric, neurological, and neurodegenerative disorders; pharmaceutical preparations for medical and therapeutic purposes for the treatment of diseases of the central nervous system, psychiatric, neurological, and neurodegenerative disorders
- Class 042 — Scientific and technological services: Providing scientific and technological information, namely, results from medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; Providing scientific information, namely, results from pharmaceutical, biomedical and biological therapeutic research; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials; providing a website featuring research and development information in the therapeutics, pharmaceutical and biotechnology fields for treatment of diseases of the central nervous system, psychiatric, neurological, and neurodegenerative disorders; research and development of therapeutics
- Class 044 — Medical, beauty and agricultural services: Providing information relating to the diagnostic, prophylactic, and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of human and veterinary neurological, neurodegenerative and other central nervous system diseases, disorders, and conditions
Owner
- Sensorium Therapeutics, Inc., Medford, MA, US
Prosecution history
- 30 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Dec 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 22 Dec 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 06 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Oct 2025 — NON-FINAL ACTION E-MAILED
- 06 Oct 2025 — NON-FINAL ACTION WRITTEN
- 11 Sept 2025 — ASSIGNED TO EXAMINER
- 27 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Apr 2025 — APPLICATION FILING RECEIPT MAILED
- 17 Apr 2025 — NEW APPLICATION ENTERED